LANKAU PETER A 4
4 · ENDO PHARMACEUTICALS HOLDINGS INC · Filed Aug 11, 2004
Insider Transaction Report
Form 4
LANKAU PETER A
SVP, US Business
Transactions
- Exercise/Conversion
Common Stock, par value $.01 per share
2004-08-09$3.00/sh+28,192$84,576→ 28,192 total - Exercise/Conversion
Common Stock, par value $.01 per share
2004-08-09$2.42/sh+26,572$64,304→ 54,764 total - Exercise/Conversion
Class C3 Stock Option
2004-08-09−28,192→ 29,153 totalExercise: $3.00From: 2004-08-09Exp: 2007-08-26→ Common Stock (28,192 underlying) - Sale
Common Stock, par value $.01 per share
2004-08-09$17.46/sh−54,764$956,179→ 0 total - Exercise/Conversion
Class C3 Stock Options
2004-08-09−26,572→ 227 totalExercise: $2.42From: 2004-08-09Exp: 2007-08-26→ Common Stock (26,572 underlying)
Footnotes (3)
- [F1]The exercisability of 28,192 Class 3 Options (at an exercise price of $3.00) was accelerated in connection with an offering of shares that closed August 9, 2004. The remaining options become exercisable upon the earlier of an Exit Event (as defined in the underlying option plan as filed with the SEC) of January 1, 2006.
- [F2]Common Stock held by Endo Pharma LLC. The exercise of these stock options did not result in the issuance of additional Common Stock by the Issuer.
- [F3]The exercisability of 26,572 Class 3 Options (at an exercise price of $2.42) was accelerated in connection with an offering of shares that closed August 9, 2004. The remaining options become exercisable upon the earlier of an Exit Event (as defined in the underlying option plan as filed with the SEC) of January 1, 2006.